The polypeptide TB 500 spray is a product that makes the polypeptide TB 500 with strong biological activity into a spray form. This type of spray provides convenience and new possibility for its application, which makes it attract much attention in the field of biomedicine. Athletes can carry it with them and quickly deal with sudden injuries during training or competition breaks, reducing suspension time due to injuries. In terms of home care, it is suitable for daily home management of small wounds, burns or chronic ulcers (such as diabetes feet) to reduce the risk of infection. For professional medical care, in rehabilitation centers or clinics, it can be used as an auxiliary treatment method, combined with other therapies to accelerate patient recovery. In other fields, such as beauty care, some studies explore its potential to improve skin condition (such as firmness and elasticity), which may expand to anti-aging or medical beauty fields.
Our products Form








TB 500 COA


The polypeptide TB 500 spray , as an innovative biological agent, shows significant convenience advantages in multiple application scenarios with its unique molecular design and multi target action mechanism.

Cardiovascular disease treatment: precise targeting, non-invasive administration
In cardiovascular diseases such as myocardial infarction and atherosclerosis, traditional treatment methods such as surgical intervention or oral drugs have problems such as high trauma and low bioavailability. Non invasive drug delivery is achieved through local skin spraying, with a molecular weight of only 889.01 Da. Its small molecule properties allow it to quickly penetrate the skin barrier and directly act on damaged myocardial or vascular endothelial cells.
Experimental data shows that in the BALB/c mouse myocardial infarction model, daily local spraying of 15 μ g/30 μ L TB 500 solution for 10 consecutive days can significantly promote angiogenesis, reduce myocardial infarction area by 37%, and improve cardiac function indicators (such as ejection fraction) by 29%. This administration method avoids the pain and infection risks of intravenous injection, and patients can operate it themselves, especially suitable for home rehabilitation scenarios.


Sports injury repair: portable and efficient, accelerating recovery cycle
Athletes or fitness enthusiasts often face acute injuries such as muscle strains and ligament tears. Its convenience is reflected in its fast onset and portability. The active ingredient Ac-T β 417-23 can inhibit the Akt signaling pathway, reduce cell apoptosis, and promote cell survival.
In the horse racing model, a single intramuscular injection of 10 mg TB 500 can significantly shorten the tendon repair time, while the spray type can achieve more accurate dose control through local spraying (for example, each spraying contains 5 mg TB 500), and does not require professional medical personnel to operate. In addition, its solid powder storage conditions (-20 ℃ for up to 3 years) and room temperature transportation characteristics make it an ideal emergency medicine for sports teams during outdoor competitions.

Skin wound healing: multi mechanism collaboration, simplifying nursing process
Chronic wounds (such as diabetes foot ulcers) often lead to delayed healing due to insufficient angiogenesis and excessive inflammatory reaction. Accelerate healing through a triple mechanism:
Promoting keratinocyte migration: Experiments have shown that TB 500 solution at 15-25 μ g/mL can enhance intracellular calcium ion flow, activate purinergic P2 receptors, and increase cell migration speed by 40%;
Stimulate angiogenesis: Upregulate VEGF expression, form a neovascularization network in dermal tissue, and provide sufficient nutrition for wounds;
Anti inflammatory effect: Inhibits the release of inflammatory factors such as TNF - α and reduces wound redness and swelling symptoms.
Clinical cases show that diabetes patients TB 500 spray (including 10 mg TB 500) on foot ulcers every day, the healing rate within two weeks is 65% higher than that of the traditional dressing group, and there is no need to change the dressing frequently, significantly reducing the nursing cost.
Daily health care: safe and gentle, suitable for a wide range of people
Convenience is also reflected in its safety and applicability. As a synthetic molecule of thymosin β 4 active fragment, it does not contain animal derived ingredients, reducing the risk of allergies. In animal experiments, no toxic reactions were observed at a single dose of 40 mg/kg (equivalent to 2800 mg per 70 kg adult), which is much higher than the therapeutic dose (10-50 mg per day).
In addition, its water solubility reaches 247.5 mg/mL, making it easy to prepare solutions of different concentrations to meet personalized needs. For example, the elderly can prevent cardiovascular aging through low concentration spray (5 mg/time), while fitness enthusiasts can use high concentration preparations (25 mg/time) to strengthen muscle repair.
Easy to operate, time-saving and labor-saving
The spray design simplifies the use process without complicated operation or professional guidance. Users only need to press the nozzle to evenly cover the damaged area, avoiding the problem of uneven application or repeated rubbing of traditional paste. For large areas or hard to reach areas (such as back and joint socket), spray has more prominent flexibility advantages, which can quickly complete cleaning and care.

Efficient penetration and rapid absorption
The spray type disperses TB 500 into fine particles through micronization technology, increases the contact area with skin or mucosa, and promotes the penetration of ingredients. Some products may combine transdermal absorption technologies (such as liposome encapsulation and nanocarriers) to further break through the skin barrier, allowing active ingredients to reach target tissues faster and shorten the onset time. This is particularly important for acute injuries or scenarios that require rapid symptom relief, such as post exercise recovery and postoperative care.
The convenience of TB 500 can not be separated from its technical breakthrough:
These characteristics enable it to play an efficient role in emergency rooms, sports fields, home care, and other scenarios, becoming an important example of peptide drugs transitioning from laboratory to clinical applications.

Summary of Pharmacokinetic Parameters
Bioavailability: The bioavailability of topical spray is affected by factors such as the application site and skin condition, but it can be significantly improved by optimizing the formulation (e.g., adding penetration enhancers).
Apparent Volume of Distribution (Vd): TB 500 has a large Vd, indicating its widespread distribution in tissues, making it particularly suitable for local treatment.
Clearance (CL): Moderate clearance maintains stable blood drug concentrations, avoiding frequent dosing.
Half-Life (t1/2): Moderate half-life ensures both sustained efficacy and avoids drug accumulation.
Pharmacokinetic analysis
The core component of TB 500 spray is the active fragment of thymosin beta 4 (TB-4), which has a molecular weight of only 889.01 Da and high permeability and biological activity. The following systematically elaborates on its in vivo processes and characteristics from four aspects: absorption, distribution, metabolism, and excretion, combined with experimental data and pharmacokinetic principles.
Non invasive administration is achieved through local skin spraying, avoiding the pain and risk of infection associated with intravenous injection. Its small molecule properties (molecular weight<1000 Da) allow it to quickly penetrate the skin barrier and enter the bloodstream. Experiments have shown that in BALB/c mouse models, after local spraying, it can quickly distribute to tissues such as myocardium and skeletal muscle, indicating high absorption efficiency. In addition, its water solubility reaches 247.5 mg/mL, making it easy to prepare solutions of different concentrations to meet personalized drug delivery needs. User feedback also confirms that there is no irritation after spraying, and the effect is rapid, suitable for immediate care of sports injuries or chronic wounds.
After spraying, it can target damaged tissues. The mechanism may be related to the following factors:
Angiogenesis induction:
By upregulating VEGF expression, it promotes angiogenesis in dermal tissue and provides sufficient nutrition for wounds. In the diabetes foot ulcer model, after spraying, the local blood flow of the wound increased significantly, and the healing speed increased by 65%.
Enhanced cell migration:
Experiments have shown that it can activate intracellular calcium ion flow, increase the migration speed of keratinocytes by 40%, and accelerate wound closure.
Organizational affinity:
It has a special affinity for tissues such as myocardium and skeletal muscle, which can form high concentration aggregates locally and enhance therapeutic effects.
Its metabolic stability is an important advantage in its pharmacokinetics. Its solid powder can be stored for 1 year at -80 ℃, avoiding the loss of activity caused by repeated freeze-thaw cycles. In the body, it is mainly metabolized by the liver, but experiments have shown that its metabolites have low activity and a moderate half-life (about several hours to several days), which can maintain stable blood drug concentrations. In addition, there is no significant induction or inhibition of cytochrome P450 (CYP450) enzymes, and the risk of drug interactions is low when used in combination with other drugs.
This substance and its metabolites are mainly excreted through the kidneys (urine) and bile (feces). Experimental data shows that approximately 60% of the dose is excreted through urine within 48 hours after a single administration, while the remaining portion is excreted through feces. This multi-channel excretion method can avoid the accumulation of drugs in the body and reduce the risk of toxicity. Safety experiments have also confirmed that even at a single dose of 40 mg/kg (equivalent to 2800 mg for 70 kg adults), no toxic reactions were observed, which is much higher than the therapeutic dose (10-50 mg per day).
Hot Tags: tb 500 spray, China tb 500 spray manufacturers, suppliers, Botulinum Toxin Injection 100iu, Nad Capsule, Nad Peptide Injection, Nad Tablet, BPC 157 Peptide Cream, BPC 157 Peptide Capsules

